Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Rader

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Nature Medicine|October 15, 1998
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient miceD Praticò, R K Tangirala, D J Rader, et al.
The Journal of Clinical Investigation|February 1, 1993
Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) productionD J Rader, W Cain, L A Zech, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1995
Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humansK Ikewaki, L A Zech, M Kindt, et al.
Chemistry and Physics of Lipids|January 1, 1994
A comparison of Lp(a) levels in fresh and frozen plasma using ELISAs with either anti-apo(a) or anti-apoB reporting antibodiesD C Usher, C Swanson, D J Rader, et al.
Advances in Experimental Medicine and Biology|January 11, 1991
Recent advances in lipoprotein metabolism and the genetic dyslipoproteinemiasH B Brewer, D J Rader, J M Hoeg, et al.
Journal of Lipid Research|May 23, 2001
Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient miceM Kawashiri, Y Zhang, D Usher, et al.
Journal of Lipid Research|December 20, 1999
Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein BU J Tietge, A Bakillah, C Maugeais, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouseK F Kozarsky, M H Donahee, J M Glick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient miceK Tsukamoto, R K Tangirala, S Chun, et al.
Journal of Lipid Research|November 11, 1991
In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-IID J Rader, G Castro, L A Zech, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Nature Medicine|October 15, 1998
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient miceD Praticò, R K Tangirala, D J Rader, et al.
The Journal of Clinical Investigation|February 1, 1993
Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) productionD J Rader, W Cain, L A Zech, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1995
Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humansK Ikewaki, L A Zech, M Kindt, et al.
Chemistry and Physics of Lipids|January 1, 1994
A comparison of Lp(a) levels in fresh and frozen plasma using ELISAs with either anti-apo(a) or anti-apoB reporting antibodiesD C Usher, C Swanson, D J Rader, et al.
Advances in Experimental Medicine and Biology|January 11, 1991
Recent advances in lipoprotein metabolism and the genetic dyslipoproteinemiasH B Brewer, D J Rader, J M Hoeg, et al.
Journal of Lipid Research|May 23, 2001
Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient miceM Kawashiri, Y Zhang, D Usher, et al.
Journal of Lipid Research|December 20, 1999
Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein BU J Tietge, A Bakillah, C Maugeais, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouseK F Kozarsky, M H Donahee, J M Glick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient miceK Tsukamoto, R K Tangirala, S Chun, et al.
Journal of Lipid Research|November 11, 1991
In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-IID J Rader, G Castro, L A Zech, et al.
Pageof 13